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Experimental findings are limited concerning efficacious procedures for facial
reanimation following persistent idiopathic facial paralysis or paresis. Additional research
examining the use of real-time integrated electromyography (iEMG) biofeedback for young
children with persistent idiopathic facial paralysis is one approach to further understand the
efficacy of electrophysiology biofeedback techniques in facial reanimation for this age group and
etiology. iEMG research has applications in interventions for pathology of nerves and muscles
affecting animation of the face. The proposed clinical case study will adopt real time iEMG
visual biofeedback to facilitate facial reanimation in a preadolescent child. Quantitative
measurements will determine orofacial muscle activation levels across 3 months of weekly facial
gesture training sessions in an academic clinical speech pathology setting. This study found
positive main effects on mid-face and perioral iEMG activation patterns related to biofeedback
session number, muscle group, and between affected and unaffected sides of the face. According
to clinical examination, the child participant demonstrated increased reanimation in the affected
mid-face related to session number with the new appearance of facial dimpling, oral angle
retraction during smile, and observed changes in extraocular posture and movement of the right
eyelid, also noted by her physician and dentist. This study illustrated the potential importance of
real time biofeedback training for facial reanimation and the efficacy of an electrophysiological

monitoring system to quantify and display facial muscle activation patterns to enhance facial
movement during emotive gestures.
Key words: communication sciences and disorders, biofeedback, orofacial muscles,
electromyography, congenital facial paralysis
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Clinical Case Study: The Effects of Real-time iEMG Biofeedback on Facial
Muscle Activation Patterns in a Child with Congenital Facial Palsy
Introduction
Facial paralysis or paresis is a rare condition that affects approximately 25-30 per
100,000 individuals per year in the United States (Bleicher et al., 1996) and is further
confounded by varying etiologies, symptoms, and subtypes (de Freitas et al., 2016). Deficits in
facial animation create variable difficulties for individuals, including diminished functional
movements (e.g., speech, eating, sucking, eye closure, blowing,
conveying emotions, etc.). The functional deficits that arise
from diminished movements may impact an individual’s ability
to engage in daily activities and communicate with others.
Therefore, treatment options are necessary to increase
reanimation and quality of life for individuals with facial
palsies.

Neuromuscular anatomy of the face.
The muscles of the face (Figure 1) produce functional

Figure 1. Lateral view of the facial
muscles (adapted from Marur et al.,
2014).

movements through their innervation by the facial nerve (CN
VII) and the trigeminal nerve (CN V). Upper face levator (frontalis and procerus) and depressor
(corrugator suupercilii, depressor supercilii) muscles participate in raising and depressing the
eyebrows. Midface levator muscles (levator labii superioris, zygomaticus major, zygomaticus
minor, levator anguli oris) participate in the movement of the oral angle, upper lip and cheeks
(i.e., smile). Other midface muscles include the buccinator and the masseter which participate in
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mastication. Finally, the muscles of the lower face include sphincter (orbicularis oris superior,
orbicularis oris inferior), retractor (risorius), and depressor (mentalis, depressor labii inferioris)
muscles. These muscle groups are involved in
various movements of the face. For instance, the
midface levators and the lower face retractor
participate in smile production, the obicularis oris
muscle is involved in lip rounding and protrusion,
and lower face depressors and the levator labii
superioris participate in frowning expressions (Marur
et al., 2014). Through careful observation and

Figure 2. Course of the facial nerve
(Medicalartlibrary.com, 2017).

measurement of facial movements, one can assess
innervation status of the muscles by CN VII
and possibly identify pathology. Upper motor
neurons originating in the face motor cortex
descend through the corticobulbar efferent
system to monosynaptically influence lower
motor neurons in the facial motor nucleus
located in the pons of the brainstem. The
facial nerve then exits the brainstem, follows the

Figure 3. Course of the trigeminal nerve (Kamal &
Toland, 2001).

cerebellopontine angle, and enters the internal auditory meatus (Figure 2). From there, it
separates into 5 branches which then innervate the muscles of the face. For the purposes of this
study, the trigeminal nerve (CN V) is also highlighted. A large role of CN V is to relay afferent
sensory information from the face to the cortex (Kamel & Toland, 2001). The trigeminal nerve
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has three branches and is largely involved in relaying afferent sensory information from the face
and tongue to the cortex (Figure 3). The mandibular branch of CN V participates in some motor
innervation of the muscles for mastication (Feroze et al., 2017).

Etiology of facial palsy.
There is clearly a multitude of muscles and branches of the facial nerve that participate in
facial kinematics, and their coordination is dependent on proper functioning of all elements.
Therefore, facial paralysis or paresis may result from varying etiologies. It is imperative that
when identifying individuals with facial paralysis, researchers understand the underlying causes
and categories that it denotes. Of these etiologies, idiopathic facial paralysis is the most common
(e.g., Bell’s palsy, paralysis without a known cause) comprising 60-75% of cases. Trauma of
CN VII or damage to its nucleus is reported to cause 2-5% of cases in population studies (Atolini
et al., 2009; Cha et al., 2008). Infection or disease (e.g., Epstein-Barr virus) account for many of
the cases of Bell’s palsy, which is due to the unknown etiology at the onset of diagnosis and then
identification of the infection later. Other causes include genetic syndrome (e.g., Moebius
syndrome) present in 1/150,000 births, developmental anomalies of CN VII (Jemec et al., 2000;
Nordjoe et al., 2018), cancer (e.g., meningioma at the cerebellopontine angle) 5-6% of cases of
CPA meningiomas result in facial palsy (Sam et al., 2017), and brainstem stroke (Aranha et al.,
2017; Deep et al., 2016; Kim et al., 2017; Kouri et al., 2018; Vogelnik & Matos, 2017). For
facial palsies with a known cause, one can identify a course of treatment such as surgery,
medication, or physical therapy (Álvarez-Argüelles et al., 2019; Sam et al., 2017), however in
others with idiopathic facial paralysis, there is a less direct path to intervention that allows
reanimation of the facial nerve.
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Similarly, on how facial paralysis can have etiologies ranging from congenital to
acquired (Corral-Romero & Bustamante-Balcárcel, 1982; Kasahara et al., 2017), symptomology
also differs based on etiology and can vary in degrees of paralysis and function. Individuals with
facial paralysis may present with bilateral or unilateral paralysis due to varied causes (Hamizan
et al., 2012; Jemec et al., 2000; Messana et al., 2018). For instance, diffuse damage to the
brainstem may present in bilateral facial paralysis if both nuclei are affected, whereas infection
to CN VII may present unilaterally. Additionally, unilateral
damage alone can yield various presentations of paralysis.
This is perhaps best illustrated by the difference between
upper motor neuron damage and subsequent facial
impairment versus damage or inflammation to CN VII and its
subsequent facial paralysis. While these both create facial
paralysis, often unilateral damage to upper motor neurons in
the sensorimotor cortex will result in contralesional impairment

Figure 4. Bell’s palsy presentation
(columbianeurology.org, 2015)

of the lower 2/3rds of the face, with droop of the oral angle with
intact movement of the upper 1/3 of the face. Alternately, with lower motor neuron damage
including the facial motor nucleus and/or facial nerve, it is more likely to observe paresis of the
entire ipsilateral face affected including forehead, maxillary, extraocular and perioral muscles
(Sam et al., 2017). Symptomology and presentation of facial paresis is important for
intervention procedures. Furthermore, etiology can also predict the longevity of symptoms. For
example, patients who manifest Bell’s palsy often recover facial movement within weeks to
months. Previous studies suggest that Bell’s palsy is the most prevalent form of facial paresis or
paralysis (Figure 4). However, it is evident that many studies classify facial palsy as Bell’s palsy
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despite the lack of confirmatory evidence. It is later when researchers identify recovery in the
participants, spontaneously or through interventions, that they can confirm the diagnosis of
Bell’s palsy (Aranha et al., 2017; Khair & Ibrahim, 2018; Poloni et al., 2018; Viteri et al., 2015).
Alternately, other causes such as meningioma or a persistent form of facial paresis typically do
not result in recovery of facial movement (Deep et al., 2016; Sam et al., 2017).

Treatment strategies for patients with facial palsy.
As previously mentioned, due to the variable presentation and symptomology, idiopathic
facial paralysis presents a further issue regarding reanimation procedures. Many case studies
identifying individuals with persistent idiopathic facial paralysis do not report consistent and
noninvasive procedures for reanimation (Nordjoe et al., 2018). The most common types of
treatment for varying etiologies are given in Table 1. Many of these treatments are specific to
known causes and not sufficient for treating persistent idiopathic facial paralysis. However, after
paralysis is deemed idiopathic due to lack of confirmatory signs for obvious etiologies (e.g.,
trauma, cancer, stroke), an individual may be put on a course of anti-inflammatory medication.
If a medication is effective and the individual recovers, the researchers then have confirmatory
evidence for Bell’s palsy. Although it appears that some medications were effective for
reanimation of idiopathic cases, they are not effective for persistent idiopathic cases and should
not be deemed reliable and consistent procedures for this population.
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Reanimation
Procedure

Etiologies
Epstein Barr Virus

Antiinflammatory
medications

Pontine stroke
Bell’s palsy
Bell’s palsy

Steroid
Medications

EBV
Idiopathic bilateral
facial palsy
Bell’s palsy

Facial
Exercises
Surgery

Intraventricular
hemorrhage
Meningioma at
cerebellopontine
angle

Effectiveness
Complete recovery in 4/5
cases; 1 persistent
Asymmetry remains @ 1 yr
Complete recovery after 1 mo

Citation
Vogelnick & Matos (2017)
Kouri et al. (2018)
Viteri et al. (2015)

2 wk recovery

Khair & Ibrahim (2018)

2 mo recovery
Recovery @ 9 mos

Álvarez-Argüelles et al.
(2019)
Messana et al. (2018)

Increased FGS score

Aranha et al. (2017)

Decreased asymmetry

Filho et al. (2015)

No improvement

Sam et al. (2017)

Table 1. Clinical efficacy for various etiologies of facial palsy.
Overall, there is an increased need for a more consistent procedure to better treat various
facial paralyses and symptomologies. Furthermore, a procedure has little validity until a valid
and reliable measure is established to identify and report characteristics of the facial paralysis as
well as changes that may occur over the course of treatment. One of the common clinical
measures for defining facial paralysis involves facial grading systems (FGS) to classify and
subjectively score movement capabilities during facial gestures (i.e., smile, etc.) (DuarteMoreiera et al., 2018; Kasahara et al., 2017; Lee et al., 2015; Pourmomeny et al., 2013). Many
scoring systems involve observation of the face resulting in qualitative reports (Lee et al., 2015).
The Sunnybrook Facial Grading Scale (FGS) focuses on three areas of observation: resting
symmetry, symmetry of voluntary movement, and synkinesis (defn: synkinesis is a neurological
symptom in which a voluntary muscle activation causes simultaneous involuntary contraction of
other muscles). These areas are rated using a Likert scale in which the movements and
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symmetry are rated as either within normal limits or highly impaired (Neely et al., 2010). An
FGS that uses a common ruler to measure static facial postures is the House-Brackmann FGS
which compares movements of the affected side to the non-affected side. The clinician rates the
patient between grade I [normal] to grade VI [total paralysis] (House & Brackmann, 1985).
Other forms of measurement include photogrammetry which involves the comparison of
orofacial flesh points estimated from still images (Filho et al., 2015; Nakamura et al., 2003).
These qualitative scales to grade the degree and location of facial paralysis at baseline and after
intervention are often inconsistent and influenced by human error. Therefore, it is important that
a physiologically-based intervention for facial reanimation be paired with an objective and
reliable form of measurement. In utilizing a more structured procedure, the clarity of progress
and results is easier to convey. One such instrumental technique that may yield quantification of
facial movement is electrophysiology (i.e., surface electromyography – sEMG) in a visuomotor
tracking paradigm which will allow the clinician-investigator to explore the correlation between
facial muscle activation patterns during baseline evaluation, and repeated-measures during the
course of therapeutic biofeedback to retrain facial muscle activation patterns.

Biofeedback.
Self-awareness is a skill that many individuals have difficulty mastering. When
considering a clinical setting, clients often have difficulty self-monitoring and require training to
increase their awareness. Biofeedback measures are proven to increase awareness of movements
and provide a method for increasing volitional control (Corral-Romero & Bustamante-Balcárcel,
1982). Feedback procedures range in modality from use of a mirror (Corral-Romero &
Bustamante-Balcárcel, 1982, Lee et al., 2015) to tape on the skin allowing participants to be
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cognizant of movements (Kasahara et al., 2017). These procedures, while providing a form of
feedback, do not yield specific and objective information regarding participant movements.
Furthermore, they do not lend to creating operational participant target responses. Biofeedback
occurs in many forms including use of a video game to increase volitional control of a muscle
(Maia et al., 2019) and EMG output paired with auditory feedback (Arpa & Ozcakir, 2019).
Researchers have sought to identify the effectiveness of biofeedback procedures in decreasing
synkinesis, increasing reanimation following paralysis due to nerve dysfunction, and reanimation
following paralysis due to muscle dysfunction (Duarte-Moreiera et al., 2018, de Freitas et al.,
2016, Pourmomeny et al., 2013). Given trained participants, biofeedback has yielded effective
results in reanimation of orofacial structures (de Freitas et al., 2016). However, there is vast
heterogeneity in the procedures that researchers use and the reanimation results due to facial
nerve deficits (Duarte-Moreiera et al., 2018). Furthermore, little research has been conducted on
iEMG biofeedback procedures for young children with congenital and persistent facial paralysis.
Study Aims.
The goal of the present clinical study was to assess the efficacy of real-time integrated
EMG visual biofeedback during repeated ‘smile’ gesture productions over 11 weeks in the
treatment of a 3-year old child with a congenital form of hemifacial paralysis.

Methods
A 3-year-old female presented to the Barkley Speech Language and Hearing Clinic
(BSLHC) at the University of Nebraska with congenital right facial paralysis. The parents
indicated that the unilateral right side facial paralysis was congenital of unknown etiology as
depicted in Figure 5. Facial paralysis presented at birth following an uncomplicated pregnancy
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and delivery. The participant exhibited an asymmetric cry and difficulty with feeding that was
first reported by the obstetrician. Subsequently, the participant was referred to several specialists
including an otolaryngologist who obtained MRI images of the temporal bone and facial
skeleton, pediatric plastic surgeon, and a neurologist. The participant underwent MRI with and
without contrast at 13-months-old. Images revealed otomastoiditis yielding opacification of the
right mastoid and middle ear which prevented effective evaluation of the right facial nerve
course at that time. Etiology of the opacification was suspected to be recent otitis media. The
diagnoses concluding this visit were Bell’s palsy, unspecified mastoiditis of the right ear, and
chronic sinusitis. Two months following neuroimaging, the participant visited a pediatric plastic
surgeon who reported a complete right facial paralysis with slight movement near the oral
commissure. The plastic surgeon suggested a follow up appointment a couple years later to
discuss treatment options including free tissue transfer reconstruction after the participant turns
5-years-old. One month later, a neurologist visit revealed no other cranial nerve deficits apart
from right facial palsy. The neurologist assessed that the palsy was likely due to utero pressure
or trauma instead of syndrome due to facial nerve symptom presentation only. Upon
presentation to BSLHC, mobility was most noticeably impaired in the right mid-face, with
reduced eye closure and corneal reflex on her right side and limited levator function in the upper
lip during smile as shown in Figure 6. Parent interview indicated this child exhibited typical
cognition, language, social interactions, and acquisition of developmental milestones.
Administration of the Goldman-Fristoe Test of Articulation 3 indicated errors for /r/, /w/, /l/ expected for her age. Test of Early Language Development 3 indicated above average receptive
language and average expressive language as per norms for age and gender. Errors included
grouping items into categories, generating inferences, and differentiating between accurate and
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inaccurate syntax – expected for her age. Oral motor exam indicated normal tongue and jaw
strength and speed with alternating and sequential motion tasks. Limited lip range of motion on
affected right side was apparent when protruding, retracting, and puckering the lips during
alternating motion tasks.

Figure 5. Participant presentation of facial palsy. From left to right: at birth, 6-weeks-old, 3months-old, and 6-months-old
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Figure 6. Participant presenting right facial paralysis during “smile” gesture.

The participant engaged in exploratory intervention sessions which began in June 2019
and consisted of facial imitation (pictures, clinician modeling), muscle exercises, somatosensory
stimulation of the affected face (pneumotactile TAC-Cell), and electromyographic (EMG)
monitoring of bilateral facial muscle groups. By September of 2019, it was decided to provide
the child with EMG biofeedback to facilitate facial muscle activity patterns during a variety of
gesture productions. EMG biofeedback sessions occurred within 15 minute sessions one time
per week. Three times per week (M/W/F), the participant was exposed to 20 minutes of
pneumotactile facial stimulation in randomized blocks at saltatory velocities ranging from 5 to
105 cm/sec. Concurrent with pneumotactile stimulation, the participant practiced facial
expressions with prompting. She participated in three facial gesture exercises, including ‘smile’,
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‘kiss’, and ‘frown’. The ‘frown’ expression was faded due to child’s emotional response, and a
sequenced ‘smile-kiss’ expression was added.
Electromyography. Hydrogel surface electrodes (Kendall H124SG, 8 mm Ag/AgCl
disc) were placed bilaterally in bipolar pairs (differential) to record from muscles groups of the
midface (maxillary levators) and lower face (perioral) as shown in Figures 7 and 8.
Biopotentials were conditioned by GRASS P511 amplifiers (Gain=20,000, Butterworth BP 301000Hz) and digitized in real time (4,000 samples/sec, 16 bits, 5V ADC, ADInstruments
PowerLab-16 [Colorado Springs, Colorado, USA]). The digitized EMG signals for each of the
four facial muscle recording sites were processed (rectified and integrated [200 ms time
constant] in real time. An expanded view of iEMG signals for affected and control mid-face
electrode placements is shown in APPENDIX I. The iEMG signals from the affected side were
displayed in real time on a 16” HD color display monitor. During these sessions, the participant
was presented with clinician models of the target gesture and visuals depicted in Figure 9. The
stimulus visuals were presented to the participant for 20 repetitions of each expression. The
presentation schedule is shown in Table 2. She was instructed to view the iEMG waveform on
the color display with direct verbal prompts presented in between each expression. Additional
verbal prompts and models were provided to demonstrate facial gestures associated with ‘little’,
‘big’, and ‘bigger’ smiles. When the participant produced expressions in natural contexts, her
attention was directed to the iEMG biofeedback display and her behavior was reinforced with
positive reinforcement from the clinician. Following each session, the iEMG signals were postprocessed to calculate the area under the iEMG waveforms over the duration of each biofeedback
session using an absolute, non-resetting integral function expressed as µV.seconds. A
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normalized iEMG value was subsequently calculated for each muscle site and expressed as
µV.seconds/second.

Figure 7. Participant with hydrogel surface electrodes during an EMG biofeedback session.
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Figure 8. Diagram of participant and the facial electromyographic recording array for real-time
biofeedback. The array included 8 mm hydrogel surface electrodes configured as bipolar
channels over the (1) right midface (R-midface), (2) right lower lip (R-LLip), (3) left midface (Lmidface), and (4) left lower lip (L-LLip). An example of integrated EMG (iEMG) is shown in
the left panel for muscles in the affected face, and an example of source EMG is shown in the
right panel for the unaffected side of the face.
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Small

Big

Biggest

Smile
Pucker
Figure 9. Stimulus prompt pictures presented to the participant by gesture type (i.e., smile and
pucker) and gesture size (i.e., small, big, biggest).

Expressions
produced in
order
‘smile’
‘pucker’
‘smile-kiss’

First 9 expressions

Last 11 expressions

1) small, 2) big, 3) biggest
All 11 ‘smile’ expressions produced at
expressions produced
biggest amplitude
consecutively (x3)
1) small, 2) big, 3) biggest
All 11 ‘pucker’ expressions produced at
expressions produced
biggest amplitude
consecutively (x3)
All 20 expressions produced with ‘smile-kiss’ alternation at biggest amplitude

Table 2. Presentation schedule of stimulus prompt pictures and participant expressions.
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Statistical Processing. Simple linear regression analyses (MTB v18.1) was used to
characterize the relation between the normalized iEMG and session number. Two-Sample Ttests with 95% confidence intervals were used to test for differences between the affected (right
face) and non-affected (left face) muscle groups, including right versus left midface, and right
versus left lower perioral face.

Results
The participant attended EMG and biofeedback sessions one time per week for the
‘smile’ expression. The final half of sessions consisted of pneumotactile sensory stimulation via
TAC cells. Stimulation was randomized and consisted of two rounds of 10 cycles. The
following data were accumulated from a series of sessions that took place at 11:00 in the
morning in the Communication Neuroscience Laboratory (BKC 140). The first two sessions
occurred on Monday and Wednesday mornings and EMG biofeedback occurred on Friday
mornings. Two EMG baseline control sessions plus nine EMG biofeedback sessions were
recorded over a period of 13 weeks between September 4th to November 22nd of 2020. The total
minutes of EMG data recording across all sessions equaled 80.5 minutes (4,828 seconds). The
average EMG data recording session was 7.3 minutes (439 seconds). The integrated EMG data
across the 11 visits are shown in Table 3. File_len is the length of the digitized data file in
seconds. The following columns demonstrate the EMG measurements for the right midface,
right lip, left midface, and left lip. These measurements are reported as integrated EMG over
session length, and normalized to integrated EMG per second.
The raw EMG waveform was full-wave rectified resulting in only positive measurements.
An envelope was created from the rectified waveform and this envelope was filtered and
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smoothed using a 0.2 sec time constant. The area under the iEMG envelope was measured using
a non-resetting absolute integral to calculate the total µV.s over each session recording. The first
column for each muscle group in Table 3 reports the total muscle bioelectric energy expressed as
an integral (µV.s) that the participant produced for each digitized record. Since individual
sessions vary in duration, iEMG data records were subsequently normalized and expressed as
µV.s/sec. Therefore, the second column for each muscle group in Table 3 represents the
normalized iEMG value as a function of session (visit) number. Statistical analyses were
performed on the normalized iEMG values across sessions and muscle groups and summarized
in APPENDIX II.
iEMG
Rmidface
(µV.s)

iEMG
R-midface
normalized
(µV.s/sec)

iEMG
R-LIP
(µV.s)

iEMG
R-LIP
normalized
(µV.s/sec)

iEMG
Lmidface
(µV.s)

iEMG
L-midface
normalized
(µV.s/sec)

iEMG
L-LIP
(µV.s)

iEMG
L-LIP
normalized
(µV.s/sec)

345
350
391
845
554
416
465
455
405
367
235

3576.5
3120.2
4356.5
15083.0
8442.2
6495.9
6103.3
7853.0
9214.1
6147.3
4336.7

10.37
8.92
11.14
17.85
15.24
15.62
13.13
17.26
22.75
16.75
18.45

10825.9
8958.2
9820.4
28249.1
29263.6
15798.4
12050.1
15473.9
20772.7
13525.3
10378.1

31.38
25.59
25.12
33.43
52.82
37.98
25.91
34.01
51.29
36.85
44.16

3859.9
3923.4
6729.0
21931.8
11086.2
8296.1
7171.8
10720.6
10619.3
9665.4
6132.1

11.19
11.21
17.21
25.95
20.01
19.94
15.42
23.56
26.22
26.34
26.09

5164.3
7707.8
10790.5
34929.2
22063.4
13786.6
12363.0
15347.8
15063.8
15353.5
10639.9

14.97
22.02
27.60
41.34
39.83
33.14
26.59
33.73
37.19
41.84
45.28

Visit

file_len
(secs)

*1
*2
3
4
5
6
7
8
9
10
11

Table 3. iEMG (µV.s) and normalized iEMG data (µV.s/sec) calculated for the ‘smile’ motor
expression task across all muscle recording sites and visits.
*Visits in which baseline data was recorded.
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Figure 10. Normalized iEMG for R-midface during ‘smile’ biofeedback gestures as a function
of session.

Simple linear regression analyses revealed that the paretic R-midface iEMG was
significantly related to session (visit) number [F (1,9) =12.83, p=.006, R2(adj) = 54.2%] with a
predicted positive growth in iEMG of 0.9392 µV.s/sec for each session. Compared to baseline,
as depicted in the first two sessions, the child participant showed a doubling of R-midface iEMG
muscle activity to approximately 20 µV.s/sec (predicted Y) over the 9 treatment sessions.
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Figure 11. Normalized iEMG for the non-affected L-midface during ‘smile’ biofeedback
gestures as a function of session.

The iEMG for the non-affected L-midface also shows a highly significant positive
relation to session number [F (1,9) =14.14, p=.004, R2(adj) = 56.8%]. The predicted y-value
(iEMG) at the 11th session was more than double in magnitude compared to session 1 (11.19
µV.s/sec compared to 26.09 µV.s/sec, respectively). The L-midface iEMG manifest a steeper
slope compared to the affected R-midface iEMG (1.388 µV.s/sec versus 0.9392 µV.s/sec).

20

Figure 12. Normalized iEMG for R-lip perioral during ‘smile’ biofeedback gestures as a
function of session.

The iEMG for the paretic R-lip perioral face is not significantly related to session number
[F (1,9) =3.01, p=.117, R2(adj) = 16.8%]. The predicted y-value (iEMG) at the 11th session is
somewhat higher in magnitude compared to session 1 (31.38 µV.s/sec compared to 44.16
µV.s/sec, respectively), but this apparent difference is not significant which is consistent with
large variation in the data and a small R-square of 16.8%. This is consistent with less significant
change compared to the L-lip perioral face (2.101 µV.s/sec versus 1.47 µV.s/sec).
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Figure 13. Normalized iEMG for the non-affected L-lip perioral during ‘smile’ biofeedback
gestures as a function of session.

The iEMG for the non-affected L-lip perioral face shows a highly significant positive
relation to session number [F (1,9) =11.11, p=.009, R2(adj) = 50.3%]. The predicted y-value
(iEMG) at the 11th session is triple in magnitude compared to session 1 (14.97 µV.s/sec
compared to 45.28 µV.s/sec, respectively). The L-lip perioral iEMG manifest a steeper slope
compared to the affected R-lip perioral iEMG (2.101 µV.s/sec versus 1.47 µV.s/sec).
To compare the effected right side to the non-affected left side, two sample t-tests were
conducted using a 95% confidence interval. Comparing the right midface to the left midface,
yielded the following results: t-value = 2.35, df = 17, and p-value = 0.031 indicating a significant
effect. The right lower lip and left lower lip comparison yielded the following results: t-value of
0.78, df = 19, and p-value = 0.444 indicating no significant effect.
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Discussion
Persistent idiopathic facial paralysis often presents variable reanimation given various
treatment techniques. In this study, real-time iEMG biofeedback was shown to promote
increased levels of muscle activation and observed reanimation in an individual with persistent
idiopathic facial paralysis. This quantitative physiological measurement and intervention can be
compared to facial grading systems which are subjective in nature (Duarte-Moreiera et al., 2018;
Kasahara et al., 2017; Lee et al., 2015; Pourmomeny et al., 2013). The results provide evidence
of the positive effects of biofeedback for reanimation of the participant’s affected mid-face.
Regression analyses revealed the strong positive relation between voluntary iEMG levels among
muscle groups in the affected (paralytic) face and session number. On average, our 3-year old
female participant achieved a growth in Right mid-face iEMG of 0.9392 µV.s/sec for each
session, with more than half of the variance in her EMG production accounted for by this
regression function [R2(adj) = 54.2%]. The positive growth in iEMG levels each week of
therapy also demonstrated that the treatment effect was greater than chance. On average, our
participant achieved a growth in the right lower lip iEMG of 1.470 µV.s/sec for each session,
however less than half of the variance in her EMG production could be accounted for by this
regression function [R2 (adj) = 16.8%.]. These findings align with previous studies indicating
the efficacy of biofeedback for increasing movement and reanimation following paralysis and the
variance in results (de Freitas et al., 2016, Maia et al., 2019). During the treatment period, the
clinical researchers noted observable changes in the participant’s face including the appearance
of a dimple on the participant’s right side and increased movement such as the ability for the
participant to furrow her eyebrows. Additionally, the participant’s dentist, who was blind to the
research procedure, commented on perceived increases in the participant’s facial range of

23
motion. These observations indicate the subjective yet practical changes which occurred during
the treatment period. Upon post-interview 11 months following the final EMG and biofeedback
session, the participant’s parents indicated that they had not observed any further changes in her
facial movement. Per clinician observation, the participant maintains asymmetry when
producing expressions and does not have the corneal reflex provided with external stimulants
(i.e., snapping near the eye). It should be noted that the participant exhibits eye closure and
reflexes when provided with pneumotactile sensory stimulation in the orbital region. However,
no objective measures were taken to determine longevity of treatment effects. They also indicate
no solidified treatment plan given the global pandemic and subsequent discontinuation of
biofeedback sessions and interventions. The participant continues to participate in activities
which maintain her quality of life including dance and school.
From parent report, medical records, and iEMG analyses it is possible that the
participant’s orofacial musculature and anatomy has regressed due to a loss/reduction of facial
motor nerve input, including atrophy of zygomatic facial muscle groups which are necessary to
produce a full smile and oral angle retraction. The extent of orofacial muscular atrophy could be
determined using 3T MRI. Further neuroimaging was previously recommended by the
participant’s otolaryngologist following inability to visualize the facial nerve course due to
opacification of the mastoid. Increasing the iEMG electrode montage over putative mid-face
zygomatic and buccinator muscle groups would be useful to increase the resolution of muscle
activation fields. Increasing the number of recording sites and decreasing the size of bipolar
iEMG recording fields (interelectrode distance) may provide additional electrophysiological
information regarding the participant’s specific areas of paresis and yield further comparisons
with the unaffected side. Although not appropriate for pediatric applications due to its invasive
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nature, the use of 40 µm hook-wire intramuscular electrodes would greatly improve the
selectivity of muscle recordings to help better define the location and extent of intact facial
muscle groups on the paretic side.

Limitations of this Clinical Study
The present report, based on clinical study of a 3-year old child with idiopathic unilateral
facial palsy, demonstrated the potent therapeutic effects of real-time EMG biofeedback over the
course of 11 weeks in a clinical speech physiology laboratory using simple non-invasive
electrophysiological methods to facilitate growth in muscle activation levels among affected
muscle groups during repetition of functional motor behaviors (i.e., smile, pucker, etc.). Further
research is required to investigate the effects of biofeedback across populations using larger
sample sizes. The global pandemic (COVID-19) prevented a formal test of EMG biofeedback
on reanimation of facial motor control in this 3-year old female presenting with unilateral
idiopathic facial palsy. Thus, the electrophysiological data and observations about facial
animation presented in this report are based on EMG and somatosensory stimulation presented
during the course of clinical intervention with this child over a period of 11 weeks during the
Fall semester 2019. The student investigator successfully created a UNL approved IRB Human
Subjects protocol, but the sudden onset of COVID-19 prevented the initiation and completion of
this study to test effects of iEMG biofeedback in combination with somatosensory interventions
on reanimation of the paralytic face.
Even in the clinical setting, it is recommended that recording procedures be more
controlled (e.g., time between expressions, further training to the concept of biofeedback,
consistent placement of electrodes, etc.). These limitations may be remediated through further
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conditioning sessions with the participant, and clear demonstration that a child participant of this
age is able to comprehend the use of biofeedback. Future directions for this study participant
include continuing with pneumotactile stimulation to investigate effectiveness in reanimating the
affected mid-face to improve facial animation (i.e., smile, lip retraction).
Clinical interventions aimed to develop/restore facial animation would benefit from a
detailed case history, including craniofacial and neuroimaging data to better understand the
presence or absence of facial muscle groups, and delineation of the presence/absence of facial
nerve branches, and congenital anomalies at or near cranial/facial skeleton foramen which may
have contributed to malformation of the peripheral distribution of the facial nerve in this child.
This may also determine her candidacy for a more invasive treatment such as a nerve and muscle
graft to restore facial kinematics, used in conjunction with EMG biofeedback and somatosensory
therapies. This procedure was previously mentioned by the participant’s pediatric plastic
surgeon and is pending possible reevaluation after the participant turns five years old. The
participant’s parents indicated their preference to avoid invasive procedures when noninvasive
ones are accessible and efficacious. These options alone, demonstrate the range of treatment
options available to individuals with facial palsy and the complex decision-making process that
each individual and family units must contemplate.
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APPENDIX I.
Expanded view of electromyographic records from the affected (red) and non-affected (blue)
mid-face facial muscles. Raw unprocessed EMG records are shown in the top panel, and the
rectified and integrated EMG (time constant = 200 ms) display used for real time biofeedback on
a 17” HD display monitor is shown in the bottom panel.
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APPENDIX II.

Two-Sample T-Test and CI:
EMG-R-midface_n, versus EMG-L-midface_n
Method
μ₁: mean of EMG-R-midface_n
µ₂: mean of EMG-L-midface_n
Difference: μ₁ - µ₂
Equal variances are not assumed for this analysis.

Descriptive Statistics
Sample

N

Mean

StDev

SE Mean

EMG-R-midface_n

11

15.22

4.06

1.2

EMG-L-midface_n

11

20.29

5.89

1.8

Estimation for Difference
95% CI for
Difference

Difference
-5.06

(-9.61, -0.51)

Test
Null hypothesis

H₀: μ₁ - µ₂ = 0

Alternative hypothesis

H₁: μ₁ - µ₂ ≠ 0

T-Value

DF

P-Value

-2.35

17

0.031
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Two-Sample T-Test and CI:
EMG-R-LIP_n versus EMG-L-LIP_n
Method
μ₁: mean of EMG-R-LIP_n
µ₂: mean of EMG-L-LIP_n
Difference: μ₁ - µ₂
Equal variances are not assumed for this analysis.

Descriptive Statistics
Sample

N

Mean

StDev

SE Mean

EMG-R-LIP_n

11

36.23

9.74

2.9

EMG-L-LIP_n

11

33.05

9.38

2.8

Estimation for Difference
Difference
3.18

95% CI for
Difference
(-5.34, 11.71)

Test
Null hypothesis

H₀: μ₁ - µ₂ = 0

Alternative hypothesis

H₁: μ₁ - µ₂ ≠ 0

T-Value

DF

P-Value

0.78

19

0.444
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Regression Analysis: EMG-R-midface_n versus SESSION
The regression equation is
EMG-R-midface_n = 9.589 + 0.9392 SESSION

Model Summary
S

R-sq

R-sq(adj)

2.74959

58.78%

54.20%

Analysis of Variance
Source

DF

SS

MS

F

P

Regression

1

97.027

97.0272

12.83

0.006

Error

9

68.042

7.5602

Total

10

165.069

Fitted Line: EMG-R-midface_n versus SESSION

Regression Analysis: EMG-R-LIP_n versus SESSION
The regression equation is
EMG-R-LIP_n = 27.41 + 1.470 SESSION

Model Summary
S

R-sq

R-sq(adj)

8.88239

25.08%

16.76%

Analysis of Variance
Source

DF

SS

MS

F

P

Regression

1

237.757

237.757

3.01

0.117

Error

9

710.072

78.897

Total

10

947.829

Fitted Line: EMG-R-LIP_n versus SESSION

34

Regression Analysis: EMG-L-midface_n versus SESSION
The regression equation is
EMG-L-midface_n = 11.96 + 1.388 SESSION

Model Summary
S

R-sq

R-sq(adj)

3.87175

61.11%

56.78%

Analysis of Variance
Source

DF

SS

MS

F

P

Regression

1

211.953

211.953

14.14

0.004

Error

9

134.914

14.990

Total

10

346.867

Fitted Line: EMG-L-midface_n versus SESSION

Regression Analysis: EMG-L-LIP_n versus SESSION
The regression equation is
EMG-L-LIP_n = 20.44 + 2.101 SESSION

Model Summary
S

R-sq

R-sq(adj)

6.61031

55.26%

50.28%

Analysis of Variance
Source

DF

SS

MS

F

P

Regression

1

485.652

485.652

11.11

0.009

Error

9

393.266

43.696

Total

10

878.918

Fitted Line: EMG-L-LIP_n versus SESSION

